Joel M. Reid - Publications, H-index & Citations

Joel M. Reid

mayo clinic

63H指数

485论文数

1.4W被引数

收录论文 95

发表时间

Efficacy and Toxicity Analysis of Selective BET Bromodomain Inhibitors in Models of Inflammatory Liver Disease 选择性BET溴结构域抑制剂的疗效和毒性分析：在炎症性肝病模型中的应用

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2025-04-14

PREAI

Doskey, Luke C.; Scholtz, Cole R.; Vail, Nora R.; Khanal, Shalil; Lee, Amani L.; Kandanur, Sai Giridhar Sarma; Hoell, Zachariah J.; Huehls, Amelia M.; Issa, Mohamed R.; Kostallari, Enis; Cao, Sheng; Reid, Joel M.; Shah, Vijay H.; Malhi, Harmeet; Pomerantz, William C. K.

The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen

BREAST CANCER RESEARCH AND TREATMENT

IF3

2025-02-27

PREAI

Safgren, Stephanie L.; Suman, Vera J.; Ferre, Roberto A. Leon; Kosel, Matthew L.; Stearns, Vered; Henry, N. Lynn; Denduluri, Neelima; Irvin, William; Ingle, James N.; Sideras, Kostantinos; Ames, Matthew M.; Reid, Joel M.; Loprinzi, Charles L.; Black, John L.; Weinshilboum, Richard M.; Goetz, Matthew P.

Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615)

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-09-01

PREAI

Foster, Jennifer H.; Reid, Joel M.; Minard, Charles; Woodfield, Sarah; Denic, Kristina Z.; Isikwei, Emasenyie; Voss, Stephan D.; Nelson, Marvin; Liu, Xiaowei; Berg, Stacey L.; Fox, Elizabeth; Weigel, Brenda J.

Entinostat as a combinatorial therapeutic for rhabdomyosarcoma

SCIENTIFIC REPORTS

IF3.9

2024-08-15

OAAI

Chauhan, Shefali; Lian, Emily; Habib, Iman; Liu, Qianqian; Anders, Nicole M.; Bugg, Megan M.; Federman, Noah C.; Reid, Joel M.; Stewart, Clinton F.; Cates, Tristan; Michalek, Joel E.; Keller, Charles

Azacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia: Children's Oncology Group trial AALL15P1

HAEMATOLOGICA

IF7.9

2024-06-13

OAAI

Guest, Erin M.; Kairalla, John A.; Devidas, Meenakshi; Hibbitts, Emily; Carroll, Andrew J.; Heerema, Nyla A.; Kubaney, Holly R.; August, Margaret A.; Ramesh, Sidharth; Yoo, Byunggil; Farooqi, Midhat S.; Pauly, Melinda G.; Wechsler, Daniel S.; Miles, Rodney R.; Reid, Joel M.; Kihei, Cynthia D.; Gore, Lia; Raetz, Elizabeth A.; Hunger, Stephen P.; Loh, Mignon L.; Brown, Patrick A.

Use of multiple pharmacodynamic measures to deconstruct the Nix-TB regimen in a short-course murine model of tuberculosis 在结核病的短期小鼠模型中使用多种药效学措施来解构nix-tb方案

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2024-05-02

OAAI

Lyons, M. A.; Obregon-Henao, A.; Ramey, M. E.; Bauman, A. A.; Pauly, S.; Rossmassler, K.; Reid, J.; Karger, B.; Walter, N. D.; Robertson, G. T.

Liposomal Phenylephrine Nanoparticles Enhance the Antitumor Activity of Intratumoral Chemotherapy in a Preclinical Model of Melanoma

ACS BIOMATERIALS SCIENCE & ENGINEERING

IF5.5

2024-04-13

PREAI

Gabriel, Emmanuel M.; Bahr, Deborah; Rachamala, Hari Krishnareddy; Madamsetty, Vijay S.; Shreeder, Barath; Bagaria, Sanjay; Escobedo, Amber L.; Reid, Joel M.; Mukhopadhyay, Debabrata

Neoadjuvant (Z)-endoxifen in premenopausal ER+, HER2-breast cancer: Evaluation of the first pharmacokinetic cohort of the EVANGELINE trial

CANCER RESEARCH

IF16.6

2024-04-05

PREAI

Goetz, Matthew P.; Suman, Vera J.; Fraser, Heather; Mina, Lida; Advani, Pooja; Leon-Ferre, Roberto; Giridhar, Karthik; Batalini, Felipe; Hunt, Katie N.; Jayaraman, Swaathi; Jakub, James; Cronin, Patricia; Piltin, Mara; Degnim, Amy; Ingle, James N.; Boughey, Judy C.; Buhrow, Sarah; Reid, Joel; Schellenberg, Matthew; Hawse, John; Quay, Steven

Partial inhibition of mitochondrial complex I ameliorates Alzheimer's disease pathology and cognition in APP/PS1 female mice(vol 4, 61, 2021)

COMMUNICATIONS BIOLOGY

IF5.1

2024-02-26

OAAI

Stojakovic, Andrea; Trushin, Sergey; Sheu, Anthony; Khalili, Layla; Chang, Su-Youne; Li, Xing; Christensen, Trace; Salisbury, Jeffrey L.; Geroux, Rachel E.; Gateno, Benjamin; Flannery, Padraig J.; Dehankar, Mrunal; Funk, Cory C.; Wilkins, Jordan; Stepanova, Anna; O'Hagan, Tara; Galkin, Alexander; Nesbitt, Jarred; Zhu, Xiujuan; Tripathi, Utkarsh; Macura, Slobodan; Tchkonia, Tamar; Pirtskhalava, Tamar; Kirkland, James L.; Kudgus, Rachel A.; Schoon, Renee A.; Reid, Joel M.; Yamazaki, Yu; Kanekiyo, Takahisa; Zhang, Song; Nemutlu, Emirhan; Dzeja, Petras; Jaspersen, Adam; Kwon, Ye In Christopher; Lee, Michael K.; Trushina, Eugenia

Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort

INVESTIGATIONAL NEW DRUGS

IF2.7

2024-01-25

PREAI

Emiloju, Oluwadunni E.; Yin, Jun; Koubek, Emily; Reid, Joel M.; Borad, Mitesh J.; Lou, Yanyan; Seetharam, Mahesh; Edelman, Martin J.; Sausville, Edward A.; Jiang, Yixing; Kaseb, Ahmed O.; Posey, James A.; Davis, Sarah L.; Gores, Gregory J.; Roberts, Lewis R.; Takebe, Naoko; Schwartz, Gary K.; Hendrickson, Andrea E. Wahner; Kaufmann, Scott H.; Adjei, Alex A.; Hubbard, Joleen M.; Costello, Brian A.

Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer

NPJ BREAST CANCER

IF7.6

2023-12-19

OAAI

Jayaraman, Swaathi; Wu, Xinyan; Kalari, Krishna R.; Tang, Xiaojia; Kuffel, Mary J.; Bruinsma, Elizabeth S.; Jalali, Shahrzad; Peterson, Kevin L.; Correia, Cristina; Kudgus, Rachel A.; Kaufmann, Scott H.; Renuse, Santosh; Ingle, James N.; Reid, Joel M.; Ames, Matthew M.; Fields, Alan P.; Schellenberg, Matthew J.; Hawse, John R.; Pandey, Akhilesh; Goetz, Matthew P.

A physiologically based pharmacokinetic modeling approach for predicting the exposure of irinotecan and its active metabolite (SN-38) in cancer patients

MOLECULAR CANCER THERAPEUTICS

IF5.5

2023-12-01

PREAI

Denic, Kristina Zoran; Neuhoff, Sibylle; Reid, Joel; Kudget, Rachel

Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma

SCIENTIFIC REPORTS

IF3.9

2023-09-01

OAAI

Kim, Jin-Ah; Crawford, Kenneth A.; Spada, Piero A.; Martin, Leah R.; Zhang, Jiaqi; Wong, Rain; Reid, Joel M.; Stewart, Clinton F.; Frank, Timothy M.; Liu, Qianqian; Michalek, Joel E.; Keller, Charles

Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2023-05-25

OAAI

Chi, Susan N.; Yi, Joanna S.; Williams, P. Mickey; Roy-Chowdhuri, Sinchita; Patton, David R.; Coffey, Brent D.; Reid, Joel M.; Piao, Jin; Saguilig, Lauren; Alonzo, Todd A.; Berg, Stacey L.; Ramirez, Nilsa C.; Jaju, Alok; Mhlanga, Joyce C.; Fox, Elizabeth; Hawkins, Douglas S.; Mooney, Margaret M.; Takebe, Naoko; Tricoli, James, V; Janeway, Katherine A.; Seibel, Nita L.; Parsons, D. Williams

Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma

CANCER

IF5.1

2023-04-20

OAAI

Cole, Kristina A.; Ijaz, Heba; Surrey, Lea F.; Santi, Mariarita; Liu, Xiaowei; Minard, Charles G.; Maris, John M.; Voss, Stephan; Reid, Joel M.; Fox, Elizabeth; Weigel, Brenda J.

Model-informed approach to support pediatric dosing for the pan-PI3K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2023-04-18

OAAI

Morcos, Peter N.; Schlender, Jan; Burghaus, Rolf; Moss, Jonathan; Lloyd, Adam; Childs, Barrett H.; Macy, Margaret E.; Reid, Joel M.; Chung, John; Garmann, Dirk

PEPN2011: a phase 1/2 study of tegavivint in children, adolescents, and young adults with recurrent or refractory solid tumors, including lymphomas and desmoid tumors: a report from the pediatric early phase clinical trials network

CANCER RESEARCH

IF16.6

2023-04-14

PREAI

Whittle, Sarah B.; Pressey, Joseph G.; Liu, Xiaowei; Minard, Charles G.; Denic, Kristina Z.; Reid, Joel M.; Berg, Stacey L.; Fox, Elizabeth; Weigel, Brenda J.

Endoxifen Downregulates AKT Phosphorylation Through Protein Kinase C Beta 1 in ER+/HER2-Breast Cancer

CANCER RESEARCH

IF16.6

2023-03-01

PREAI

Jayaraman, Swaathi; Wu, Xinyan; Kalari, Krishna R.; Tang, Xiaojia; Kuffel, Mary; Bruinsma, Elizabeth S.; Renuse, Santosh; Ingle, James N.; Reid, Joel; Schellenberg, Matthew; Hawse, John; Pandey, Akhilesh; Goetz, Matthew P.

A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children?s Oncology Group Study ADVL1412 br

CLINICAL CANCER RESEARCH

IF10.2

2022-10-03

OAAI

Davis, Kara L.; Fox, Elizabeth; Isikwei, Emasenyie; Reid, Joel M.; Liu, Xiaowei; Minard, Charles G.; Voss, Stephan; Berg, Stacey L.; Weigel, Brenda J.; Mackall, Crystal L.

Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium study

NEURO-ONCOLOGY ADVANCES

IF4.1

2022-05-20

OAAI

Mueller, Sabine; Cooney, Tabitha; Yang, Xiaodong; Pal, Sharmistha; Ermoian, Ralph; Gajjar, Amar; Liu, Xiaowei; Prem, Komal; Minard, Charles G.; Reid, Joel M.; Nelson, Marvin; Haas-Kogan, Daphne; Fox, Elizabeth; Weigel, Brenda J.

研究方向